BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lewis JR, Mohanty SR. Nonalcoholic Fatty Liver Disease: A Review and Update. Dig Dis Sci 2010;55:560-78. [DOI: 10.1007/s10620-009-1081-0] [Cited by in Crossref: 212] [Cited by in F6Publishing: 211] [Article Influence: 17.7] [Reference Citation Analysis]
Number Citing Articles
1 Sado DM, Flett AS, Moon JC. Novel imaging techniques for diffuse myocardial fibrosis. Future Cardiol. 2011;7:643-650. [PMID: 21929344 DOI: 10.2217/fca.11.45] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
2 El Kamari V, Hileman CO, Gholam PM, Kulkarni M, Funderburg N, McComsey GA. Statin Therapy Does Not Reduce Liver Fat Scores in Patients Receiving Antiretroviral Therapy for HIV Infection. Clin Gastroenterol Hepatol 2019;17:536-542.e1. [PMID: 29908359 DOI: 10.1016/j.cgh.2018.05.058] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mazo DF, de Oliveira MG, Pereira IV, Cogliati B, Stefano JT, de Souza GF, Rabelo F, Lima FR, Ferreira Alves VA, Carrilho FJ. S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis. Drug Des Devel Ther. 2013;7:553-563. [PMID: 23843692 DOI: 10.2147/dddt.s43930] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
4 Bastati N, Feier D, Wibmer A, Traussnigg S, Balassy C, Tamandl D, Einspieler H, Wrba F, Trauner M, Herold C, Ba-Ssalamah A. Noninvasive differentiation of simple steatosis and steatohepatitis by using gadoxetic acid-enhanced MR imaging in patients with nonalcoholic fatty liver disease: a proof-of-concept study. Radiology. 2014;271:739-747. [PMID: 24576046 DOI: 10.1148/radiol.14131890] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 6.1] [Reference Citation Analysis]
5 Han SJ, Choi SE, Yi SA, Jung JG, Jung IR, Shin M, Kang S, Oh H, Kim HJ, Kim DJ, Kwon JE, Choi CS, Lee KW, Kang Y. Glutamate dehydrogenase activator BCH stimulating reductive amination prevents high fat/high fructose diet-induced steatohepatitis and hyperglycemia in C57BL/6J mice. Sci Rep 2016;5:37468. [PMID: 27874078 DOI: 10.1038/srep37468] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
6 Souza AF, Pace FH, Chebli JM, Ferreira LE. Insulin resistance in non-diabetic patients with chronic hepatitis C: what does it mean? Arq Bras Endocrinol Metabol 2011;55:412-8. [PMID: 22011858 DOI: 10.1590/s0004-27302011000600008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
7 Abenavoli L. Metformin: a therapeutic option for treating nonalcoholic fatty liver disease. Dig Dis Sci 2010;55:2121. [PMID: 20490678 DOI: 10.1007/s10620-010-1279-1] [Reference Citation Analysis]
8 Chou CF, Zhu X, Lin YY, Gamble KL, Garvey WT, Chen CY. KSRP is critical in governing hepatic lipid metabolism through controlling Per2 expression. J Lipid Res 2015;56:227-40. [PMID: 25514904 DOI: 10.1194/jlr.M050724] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
9 Martin-benitez G, Marti-bonmati L, Barber C, Vila R. Hepatic lipomas and steatosis: An association beyond chance. European Journal of Radiology 2012;81:e491-4. [DOI: 10.1016/j.ejrad.2011.06.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Yang P, Wu H, Chung H, Chen C, Chi C, Yeh C, Cheng J. Rilmenidine improves hepatic steatosis through p38-dependent pathway to higher the expression of farnesoid X receptor. Naunyn-Schmiedeberg's Arch Pharmacol 2012;385:51-6. [DOI: 10.1007/s00210-011-0691-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
11 Famouri F, Shariat Z, Hashemipour M, Keikha M, Kelishadi R. Effects of Probiotics on Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents. J Pediatr Gastroenterol Nutr 2017;64:413-7. [PMID: 28230607 DOI: 10.1097/MPG.0000000000001422] [Cited by in Crossref: 89] [Cited by in F6Publishing: 44] [Article Influence: 22.3] [Reference Citation Analysis]
12 Wang S, Lei T, Zhou L, Zheng H, Zeng C, Liu N, Yang Z, Chen X. Functional analysis and transcriptional regulation of porcine six transmembrane epithelial antigen of prostate 4 (STEAP4) gene and its novel variant in hepatocytes. The International Journal of Biochemistry & Cell Biology 2013;45:612-20. [DOI: 10.1016/j.biocel.2012.12.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
13 Ke F, Xue G, Jiang X, Li F, Lai X, Zhang M, Shen Y, Gao L. Combination of asprosin and adiponectin as a novel marker for diagnosing non-alcoholic fatty liver disease. Cytokine 2020;134:155184. [PMID: 32645536 DOI: 10.1016/j.cyto.2020.155184] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Xu Y, Hu S, Jadhav K, Zhu Y, Pan X, Bawa FC, Yin L, Zhang Y. Hepatocytic Activating Transcription Factor 3 Protects Against Steatohepatitis via Hepatocyte Nuclear Factor 4α. Diabetes 2021;70:2506-17. [PMID: 34475098 DOI: 10.2337/db21-0181] [Reference Citation Analysis]
15 Navarro LA, Wree A, Povero D, Berk MP, Eguchi A, Ghosh S, Papouchado BG, Erzurum SC, Feldstein AE. Arginase 2 deficiency results in spontaneous steatohepatitis: a novel link between innate immune activation and hepatic de novo lipogenesis. J Hepatol. 2015;62:412-420. [PMID: 25234945 DOI: 10.1016/j.jhep.2014.09.015] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 5.3] [Reference Citation Analysis]
16 Wu HT, Lu FH, Ou HY, Su YC, Hung HC, Wu JS, Yang YC, Wu CL, Chang CJ. The role of hepassocin in the development of non-alcoholic fatty liver disease. J Hepatol 2013;59:1065-72. [PMID: 23792031 DOI: 10.1016/j.jhep.2013.06.004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
17 Bi X, Liu W, Xia X, Chen L, Mu T, Liu J, Hou Y, Zhao Y. Effects of Callistephus chinensis flower polyphones on improving metabolic disorders in high-fat diet-induced mice. Food Funct 2014;5:3304-10. [PMID: 25367327 DOI: 10.1039/c4fo00637b] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Kordi-tamandani DM, Hashemi M, Birjandian E, Bahari A, Valizadeh J, Torkamanzehi A. Lack of association of GSTT1 and GSTP1 genes methylation and their expression profiles with risk of NAFLD in a sample of Iranian patients. Clinics and Research in Hepatology and Gastroenterology 2011;35:387-92. [DOI: 10.1016/j.clinre.2011.01.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
19 Feng Q, Gou XJ, Meng SX, Huang C, Zhang YQ, Tang YJ, Wang WJ, Xu L, Peng JH, Hu YY. Qushi Huayu Decoction Inhibits Hepatic Lipid Accumulation by Activating AMP-Activated Protein Kinase In Vivo and In Vitro. Evid Based Complement Alternat Med 2013;2013:184358. [PMID: 23573117 DOI: 10.1155/2013/184358] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
20 Feitosa MF, Wojczynski MK, North KE, Zhang Q, Province MA, Carr JJ, Borecki IB. The ERLIN1-CHUK-CWF19L1 gene cluster influences liver fat deposition and hepatic inflammation in the NHLBI Family Heart Study. Atherosclerosis. 2013;228:175-180. [PMID: 23477746 DOI: 10.1016/j.atherosclerosis.2013.01.038] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
21 Trovato GM, Martines GF, Trovato FM, Pirri C, Pace P, Garozzo A, Castro A, Catalano D. Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance. Dig Dis Sci. 2012;57:535-544. [PMID: 21953137 DOI: 10.1007/s10620-011-1903-8] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
22 Kamiya T, Sameshima-Kamiya M, Nagamine R, Tsubata M, Ikeguchi M, Takagaki K, Shimada T, Aburada M. The crude extract from puerariae flower exerts antiobesity and antifatty liver effects in high-fat diet-induced obese mice. Evid Based Complement Alternat Med. 2012;2012:272710. [PMID: 22685484 DOI: 10.1155/2012/272710] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
23 Idilman IS, Tuzun A, Savas B, Elhan AH, Celik A, Idilman R, Karcaaltincaba M. Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty liver disease. Abdom Imaging 2015;40:1512-9. [PMID: 25715922 DOI: 10.1007/s00261-015-0385-0] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 8.5] [Reference Citation Analysis]
24 Huang YY, Gusdon AM, Qu S. Cross-talk between the thyroid and liver: A new target for nonalcoholic fatty liver disease treatment. World J Gastroenterol 2013; 19(45): 8238-8246 [PMID: 24363514 DOI: 10.3748/wjg.v19.i45.8238] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
25 Jamialahmadi T, Nematy M, Jangjoo A, Goshayeshi L, Abdalla MA, Akhlaghi S, Sathyapalan T, Sahebkar A. The predictive role of parathyroid hormone for non-alcoholic fatty liver disease based on invasive and non-invasive findings in candidates of bariatric surgery. Eat Weight Disord 2021. [PMID: 33999371 DOI: 10.1007/s40519-021-01151-2] [Reference Citation Analysis]
26 Moriya T, Kitamori K, Naito H, Yanagiba Y, Ito Y, Yamagishi N, Tamada H, Jia X, Tsuchikura S, Ikeda K, Yamori Y, Nakajima T. Simultaneous changes in high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis and those underlying molecular mechanisms in novel SHRSP5/Dmcr rat. Environ Health Prev Med 2012;17:444-56. [PMID: 22407906 DOI: 10.1007/s12199-012-0273-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
27 Tsuda N, Matsui O. Signal profile on Gd-EOB-DTPA-enhanced MR imaging in non-alcoholic steatohepatitis and liver cirrhosis induced in rats: correlation with transporter expression. Eur Radiol. 2011;21:2542-2550. [PMID: 21830099 DOI: 10.1007/s00330-011-2228-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
28 Abreu IC, Guerra JF, Pereira RR, Silva M, Lima WG, Silva ME, Pedrosa ML. Hypercholesterolemic diet induces hepatic steatosis and alterations in mRNA expression of NADPH oxidase in rat livers. Arq Bras Endocrinol Metabol 2014;58:251-9. [PMID: 24863087 DOI: 10.1590/0004-2730000002831] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
29 Kleuser B. Divergent Role of Sphingosine 1-Phosphate in Liver Health and Disease. Int J Mol Sci. 2018;19. [PMID: 29510489 DOI: 10.3390/ijms19030722] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
30 Kanerva N, Sandboge S, Kaartinen NE, Männistö S, Eriksson JG. Higher fructose intake is inversely associated with risk of nonalcoholic fatty liver disease in older Finnish adults. Am J Clin Nutr. 2014;100:1133-1138. [PMID: 25099548 DOI: 10.3945/ajcn.114.086074] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
31 Dichtel LE, Eajazi A, Miller KK, Torriani M, Bredella MA. Short- and Long-Term Reproducibility of Intrahepatic Lipid Quantification by 1H-MR Spectroscopy and CT in Obesity. J Comput Assist Tomogr 2016;40:678-82. [PMID: 27116479 DOI: 10.1097/RCT.0000000000000423] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
32 Chang K, Lin J, Chen S, Weng M, Yen G. Silymarin protects against high fat diet-evoked metabolic injury by induction of glucagon-like peptide 1 and sirtuin 1. Journal of Functional Foods 2019;56:136-44. [DOI: 10.1016/j.jff.2019.03.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
33 Li S, Liao X, Meng F, Wang Y, Sun Z, Guo F, Li X, Meng M, Li Y, Sun C. Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats. PLoS One. 2014;9:e86724. [PMID: 24489777 DOI: 10.1371/journal.pone.0086724] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 9.0] [Reference Citation Analysis]
34 Kahraman A, Fingas CD, Syn WK, Gerken G, Canbay A. Role of stress-induced NKG2D ligands in liver diseases. Liver Int. 2012;32:370-382. [PMID: 22097967 DOI: 10.1111/j.1478-3231.2011.02608.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
35 Gou XJ, Feng Q, Fan LL, Zhu J, Hu YY. Serum and Liver Tissue Metabonomic Study on Fatty Liver in Rats Induced by High-Fat Diet and Intervention Effects of Traditional Chinese Medicine Qushi Huayu Decoction. Evid Based Complement Alternat Med 2017;2017:6242697. [PMID: 29018486 DOI: 10.1155/2017/6242697] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
36 Lombardo E, van Roomen CP, van Puijvelde GH, Ottenhoff R, van Eijk M, Aten J, Kuiper J, Overkleeft HS, Groen AK, Verhoeven AJ. Correction of liver steatosis by a hydrophobic iminosugar modulating glycosphingolipids metabolism. PLoS One. 2012;7:e38520. [PMID: 23056165 DOI: 10.1371/journal.pone.0038520] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
37 Wang W, Zhou W, Wang B, Zhu H, Ye L, Feng M. Antioxidant effect of apolipoprotein A-I on high-fat diet-induced non-alcoholic fatty liver disease in rabbits. Acta Biochim Biophys Sin (Shanghai) 2013;45:95-103. [PMID: 23174676 DOI: 10.1093/abbs/gms100] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
38 Ferré P, Foufelle F. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes Metab. 2010;12 Suppl 2:83-92. [PMID: 21029304 DOI: 10.1111/j.1463-1326.2010.01275.x] [Cited by in Crossref: 406] [Cited by in F6Publishing: 385] [Article Influence: 36.9] [Reference Citation Analysis]
39 Mannery YO, McClain CJ, Vos MB. Keratin 18, Apoptosis, and Liver Disease in Children. Curr Pediatr Rev 2011;7:310-5. [PMID: 25346653 DOI: 10.2174/157339611796892364] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
40 Wu R, Zhang W, Liu B, Gao J, Xiao XQ, Zhang F, Zhou HM, Wu XL, Zhang X. Probucol ameliorates the development of nonalcoholic steatohepatitis in rats fed high-fat diets. Dig Dis Sci 2013;58:163-71. [PMID: 22878918 DOI: 10.1007/s10620-012-2335-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
41 Hoffmann CJ, Hoffmann JD, Kensler C, van der Watt M, Omar T, Chaisson RE, Martinson NA, Variava E. Tuberculosis and hepatic steatosis are prevalent liver pathology findings among HIV-infected patients in South Africa. PLoS One. 2015;10:e0117813. [PMID: 25668620 DOI: 10.1371/journal.pone.0117813] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
42 Yang YJ, Bang CS, Shin SP, Baik GH. Clinical impact of non-alcoholic fatty liver disease on the occurrence of colorectal neoplasm: Propensity score matching analysis. PLoS One 2017;12:e0182014. [PMID: 28777831 DOI: 10.1371/journal.pone.0182014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
43 Sheng L, Liu Y, Jiang L, Chen Z, Zhou Y, Cho KW, Rui L. Hepatic SH2B1 and SH2B2 regulate liver lipid metabolism and VLDL secretion in mice. PLoS One. 2013;8:e83269. [PMID: 24358267 DOI: 10.1371/journal.pone.0083269] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
44 Kim M, Lee HA, Cho HM, Kang SH, Lee E, Kim IK. Histone deacetylase inhibition attenuates hepatic steatosis in rats with experimental Cushing's syndrome. Korean J Physiol Pharmacol 2018;22:23-33. [PMID: 29302209 DOI: 10.4196/kjpp.2018.22.1.23] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
45 Goceri E, Shah ZK, Layman R, Jiang X, Gurcan MN. Quantification of liver fat: A comprehensive review. Comput Biol Med 2016;71:174-89. [PMID: 26945465 DOI: 10.1016/j.compbiomed.2016.02.013] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 6.2] [Reference Citation Analysis]
46 Naik A, Belič A, Zanger UM, Rozman D. Molecular Interactions between NAFLD and Xenobiotic Metabolism. Front Genet 2013;4:2. [PMID: 23346097 DOI: 10.3389/fgene.2013.00002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
47 Lee J, Park J, Roh YS. Molecular insights into the role of mitochondria in non-alcoholic fatty liver disease. Arch Pharm Res 2019;42:935-46. [DOI: 10.1007/s12272-019-01178-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
48 Fierbinteanu-Braticevici C, Dina I, Petrisor A, Tribus L, Negreanu L, Carstoiu C. Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis. World J Gastroenterol. 2010;16:4784-4791. [PMID: 20939106 DOI: 10.3748/wjg.v16i38.4784] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Kim S, Choi J, Kim M. Insulin resistance, inflammation, and nonalcoholic fatty liver disease in non-obese adults without metabolic syndrome components. Hepatol Int. 2013;7:586-591. [PMID: 26201791 DOI: 10.1007/s12072-012-9412-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
50 Toshikuni N, Fukumura A, Hayashi N, Nomura T, Tsuchishima M, Arisawa T, Tsutsumi M. Comparison of the relationships of alcoholic and nonalcoholic fatty liver with hypertension, diabetes mellitus, and dyslipidemia. J Clin Biochem Nutr. 2013;52:82-88. [PMID: 23341703 DOI: 10.3164/jcbn.12-55] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
51 Hur W, Lee JH, Kim SW, Kim JH, Bae SH, Kim M, Hwang D, Kim YS, Park T, Um SJ. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway. Int J Biochem Cell Biol. 2015;64:265-276. [PMID: 25957914 DOI: 10.1016/j.biocel.2015.04.016] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 8.7] [Reference Citation Analysis]
52 Beyazit Y, Purnak T, Kekilli M. Omega-3 Fatty Acids: A Promising Alternative Treatment Approach for Patients with Nonalcoholic Fatty Liver Disease. Dig Dis Sci 2010;55:2422-3. [DOI: 10.1007/s10620-010-1269-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
53 Aldámiz-echevarría L, de las Heras J, Couce ML, Alcalde C, Vitoria I, Bueno M, Blasco-alonso J, Concepción García M, Ruiz M, Suárez R, Andrade F, Villate O. Non-alcoholic fatty liver in hereditary fructose intolerance. Clinical Nutrition 2020;39:455-9. [DOI: 10.1016/j.clnu.2019.02.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
54 Demir M, Lang S, Schlattjan M, Drebber U, Wedemeyer I, Nierhoff D, Kaul I, Sowa J, Canbay A, Töx U, Steffen HM. NIKEI: a new inexpensive and non-invasive scoring system to exclude advanced fibrosis in patients with NAFLD. PLoS One 2013;8:e58360. [PMID: 23555578 DOI: 10.1371/journal.pone.0058360] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
55 Kang CM, Lee JH. Pathophysiology after pancreaticoduodenectomy. World J Gastroenterol 2015; 21(19): 5794-5804 [PMID: 26019443 DOI: 10.3748/wjg.v21.i19.5794] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
56 Motomura W, Yoshizaki T, Takahashi N, Kumei S, Mizukami Y, Jang SJ, Kohgo Y. Analysis of vanin-1 upregulation and lipid accumulation in hepatocytes in response to a high-fat diet and free fatty acids. J Clin Biochem Nutr 2012;51:163-9. [PMID: 23170042 DOI: 10.3164/jcbn.12-06] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
57 Song HY, Mao ZM, Yang LL, Liu T, Li DF, Zhang L, Ge YL, Zheng PY, Liu P, Zhang XQ. Dangfei liganning capsules attenuate the susceptibility of rat nonalcoholic fatty liver to carbon tetrachloride toxicity. J Tradit Chin Med. 2011;31:327-333. [PMID: 22462240 DOI: 10.1016/S0254-6272(12)60013-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
58 Wang A, Li M, Huang H, Xiao Z, Shen J, Zhao Y, Yin J, Kaboli PJ, Cao J, Cho CH, Wang Y, Li J, Wu X. A review of Penthorum chinense Pursh for hepatoprotection: Traditional use, phytochemistry, pharmacology, toxicology and clinical trials. Journal of Ethnopharmacology 2020;251:112569. [DOI: 10.1016/j.jep.2020.112569] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
59 Liu Y, Jiang L, Sun C, Ireland N, Shah YM, Liu Y, Rui L. Insulin/Snail1 axis ameliorates fatty liver disease by epigenetically suppressing lipogenesis. Nat Commun 2018;9:2751. [PMID: 30013137 DOI: 10.1038/s41467-018-05309-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
60 Heeba GH, Morsy MA. Fucoidan ameliorates steatohepatitis and insulin resistance by suppressing oxidative stress and inflammatory cytokines in experimental non-alcoholic fatty liver disease. Environ Toxicol Pharmacol. 2015;40:907-914. [PMID: 26498267 DOI: 10.1016/j.etap.2015.10.003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
61 Schady DA, Roy A, Finegold MJ. Liver tumors in children with metabolic disorders. Transl Pediatr. 2015;4:290-303. [PMID: 26835391 DOI: 10.3978/j.issn.2224-4336.2015.10.08] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
62 Bayat M, Daei S, Ziamajidi N, Abbasalipourkabir R, Nourian A. The protective effects of vitamins A, C, and E on zinc oxide nanoparticles (ZnO NPs)-induced liver oxidative stress in male Wistar rats. Drug Chem Toxicol 2021;:1-10. [PMID: 34915775 DOI: 10.1080/01480545.2021.2016809] [Reference Citation Analysis]
63 Ghosh S, Kaw M, Patel PR, Ledford KJ, Bowman TA, McInerney MF, Erickson SK, Bourey RE, Najjar SM. Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. Hepat Med 2010;2010:69-78. [PMID: 21949477 DOI: 10.2147/HMER.S8902] [Cited by in Crossref: 3] [Cited by in F6Publishing: 17] [Article Influence: 0.3] [Reference Citation Analysis]
64 Tabori H, Jaudszus A, Arnold C, Mentzel HJ, Lorenz M, Michl RK, Lehmann T, Renz DM, Mainz JG. Relation of Ultrasound Findings and Abdominal Symptoms obtained with the CFAbd-Score in Cystic Fibrosis Patients. Sci Rep 2017;7:17465. [PMID: 29234058 DOI: 10.1038/s41598-017-17302-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
65 Ued Fda V, Weffort VR. Antioxidant vitamins in the context of nonalcoholic fatty liver disease in obese children and adolescents. Rev Paul Pediatr 2013;31:523-30. [PMID: 24473959 DOI: 10.1590/S0103-05822013000400016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
66 Xu Y, Zhu Y, Hu S, Xu Y, Stroup D, Pan X, Bawa FC, Chen S, Gopoju R, Yin L, Zhang Y. Hepatocyte Nuclear Factor 4α Prevents the Steatosis-to-NASH Progression by Regulating p53 and Bile Acid Signaling (in mice). Hepatology 2021;73:2251-65. [PMID: 33098092 DOI: 10.1002/hep.31604] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
67 DeSantis DA, Ko CW, Wang L, Lee P, Croniger CM. Constitutive Activation of the Nlrc4 Inflammasome Prevents Hepatic Fibrosis and Promotes Hepatic Regeneration after Partial Hepatectomy. Mediators Inflamm 2015;2015:909827. [PMID: 26635450 DOI: 10.1155/2015/909827] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
68 Feitosa MF, Reiner AP, Wojczynski MK, Graff M, North KE, Carr JJ, Borecki IB. Sex-influenced association of nonalcoholic fatty liver disease with coronary heart disease. Atherosclerosis. 2013;227:420-424. [PMID: 23390892 DOI: 10.1016/j.atherosclerosis.2013.01.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
69 Ahsan F, Oliveri F, Goud HK, Mehkari Z, Mohammed L, Javed M, Althwanay A, Rutkofsky IH. Pleiotropic Effects of Statins in the Light of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. Cureus 2020;12:e10446. [PMID: 33072455 DOI: 10.7759/cureus.10446] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Panchal SK, Poudyal H, Arumugam TV, Brown L. Rutin attenuates metabolic changes, nonalcoholic steatohepatitis, and cardiovascular remodeling in high-carbohydrate, high-fat diet-fed rats. J Nutr. 2011;141:1062-1069. [PMID: 21508207 DOI: 10.3945/jn.111.137877] [Cited by in Crossref: 108] [Cited by in F6Publishing: 99] [Article Influence: 9.8] [Reference Citation Analysis]
71 Ko JS. Nonalcoholic Fatty Liver Disease. Korean J Gastroenterol 2010;56:6. [DOI: 10.4166/kjg.2010.56.1.6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
72 Zhan YT, Su HY, An W. Glycosyltransferases and non-alcoholic fatty liver disease. World J Gastroenterol 2016; 22(8): 2483-2493 [PMID: 26937136 DOI: 10.3748/wjg.v22.i8.2483] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
73 Liu W, Baker SS, Baker RD, Nowak NJ, Zhu L. Upregulation of hemoglobin expression by oxidative stress in hepatocytes and its implication in nonalcoholic steatohepatitis. PLoS One 2011;6:e24363. [PMID: 21931690 DOI: 10.1371/journal.pone.0024363] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 6.4] [Reference Citation Analysis]
74 Tian X, Ru Q, Xiong Q, Wen R, Chen Y. Catalpol Attenuates Hepatic Steatosis by Regulating Lipid Metabolism via AMP-Activated Protein Kinase Activation. Biomed Res Int 2020;2020:6708061. [PMID: 32420361 DOI: 10.1155/2020/6708061] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
75 Mazo DF, Lima VM, Stefano JT, Rabelo F, Faintuch J, Oliveira CP. Gluco-lipidic indices in treated hypothyroidism associated with nonalcoholic fatty liver disease. Arq Gastroenterol 2011;48:186-9. [PMID: 21952703 DOI: 10.1590/s0004-28032011000300006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
76 Vakhrushev YM, Lukashevich АР, Penkina IA, Suchkova EV. Comparative analysis of bile acid spectrum in non-alcoholic fatty liver disease and cholelithiasis. Ter Arkh 2019;91:48-51. [PMID: 31094171 DOI: 10.26442/ 00403660.2019.02.000105] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
77 Del Prete A, Iadevaia M, Loguercio C. The role of gut hormones in controlling the food intake. What is their role in emerging diseases? Endocrinología y Nutrición 2012;59:197-206. [DOI: 10.1016/j.endonu.2011.11.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
78 Hammes TO, Pedroso GL, Hartmann CR, Escobar TDC, Fracasso LB, da Rosa DP, Marroni NP, Porawski M, da Silveira TR. The Effect of Taurine on Hepatic Steatosis Induced by Thioacetamide in Zebrafish (Danio rerio). Dig Dis Sci 2012;57:675-82. [DOI: 10.1007/s10620-011-1931-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
79 Barbuti RC, Schiavon LL, Oliveira CP, Alvares-DA-Silva MR, Sassaki LY, Passos MDCF, Farias AQ, Barros LL, Barreto BP, Albuquerque GBML, Alves AM, Navarro-Rodriguez T, Bittencourt PL. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN GASTROINTESTINAL AND LIVER DISEASES: PROCEEDINGS OF A JOINT MEETING OF THE BRAZILIAN SOCIETY OF HEPATOLOGY (SBH), BRAZILIAN NUCLEUS FOR THE STUDY OF HELICOBACTER PYLORI AND MICROBIOTA (NBEHPM), AND BRAZILIAN FEDERATION OF GASTROENTEROLOGY (FBG). Arq Gastroenterol 2020;57:381-98. [PMID: 33331485 DOI: 10.1590/S0004-2803.202000000-72] [Reference Citation Analysis]
80 Fan M, Choi YJ, Tang Y, Bae SM, Yang HP, Kim EK. Efficacy and Mechanism of Polymerized Anthocyanin from Grape-Skin Extract on High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease. Nutrients 2019;11:E2586. [PMID: 31717842 DOI: 10.3390/nu11112586] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
81 Chen SH, He F, Zhou HL, Wu HR, Xia C, Li YM. Relationship between nonalcoholic fatty liver disease and metabolic syndrome. J Dig Dis. 2011;12:125-130. [PMID: 21401898 DOI: 10.1111/j.1751-2980.2011.00487.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 4.4] [Reference Citation Analysis]
82 Peyrou M, Ramadori P, Bourgoin L, Foti M. PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs. PPAR Res 2012;2012:757803. [PMID: 23024649 DOI: 10.1155/2012/757803] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
83 Su M, Guo C, Liu M, Liang X, Yang B. Therapeutic targets of vitamin C on liver injury and associated biological mechanisms: A study of network pharmacology. International Immunopharmacology 2019;66:383-7. [DOI: 10.1016/j.intimp.2018.11.048] [Cited by in Crossref: 36] [Cited by in F6Publishing: 43] [Article Influence: 12.0] [Reference Citation Analysis]
84 Fernández-Domínguez I, Echevarria-Uraga JJ, Gómez N, Luka Z, Wagner C, Lu SC, Mato JM, Martínez-Chantar ML, Rodríguez-Cuesta J. High-frequency ultrasound imaging for longitudinal evaluation of non-alcoholic fatty liver disease progression in mice. Ultrasound Med Biol 2011;37:1161-9. [PMID: 21645964 DOI: 10.1016/j.ultrasmedbio.2011.04.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
85 Rezazadeh A, Yazdanparast R. Prevention of nonalcoholic steatohepatitis in rats by two manganese-salen complexes. Iran Biomed J 2014;18:41-8. [PMID: 24375162 DOI: 10.6091/ibj.1201.2013] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
86 Heba ER, Desai A, Zand KA, Hamilton G, Wolfson T, Schlein AN, Gamst A, Loomba R, Sirlin CB, Middleton MS. Accuracy and the effect of possible subject-based confounders of magnitude-based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference. J Magn Reson Imaging. 2016;43:398-406. [PMID: 26201284 DOI: 10.1002/jmri.25006] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
87 Lei H, denDekker AD, Li G, Zhang Z, Sha L, Schaller MA, Kunkel SL, Rui L, Tao K, Dou Y. Dysregulation of intercellular signaling by MOF deletion leads to liver injury. J Biol Chem 2021;296:100235. [PMID: 33376138 DOI: 10.1074/jbc.RA120.016079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
88 Matsuda Y, Wakai T, Hirose Y, Osawa M, Fujimaki S, Kubota M. p27 Is a critical prognostic biomarker in non-alcoholic steatohepatitis-related hepatocellular carcinoma. Int J Mol Sci 2013;14:23499-515. [PMID: 24351862 DOI: 10.3390/ijms141223499] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
89 Ou HY, Wu HT, Lu FH, Su YC, Hung HC, Wu JS, Yang YC, Wu CL, Chang CJ. Activation of free fatty acid receptor 1 improves hepatic steatosis through a p38-dependent pathway. J Mol Endocrinol. 2014;53:165-174. [PMID: 25008074 DOI: 10.1530/jme-14-0003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
90 Yndestad A, Haukeland JW, Dahl TB, Halvorsen B, Aukrust P. Activin A in Nonalcoholic Fatty Liver Disease. Activins and Inhibins. Elsevier; 2011. pp. 323-42. [DOI: 10.1016/b978-0-12-385961-7.00015-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
91 Kalantari F, Bergeron JJ, Nilsson T. Biogenesis of lipid droplets--how cells get fatter. Mol Membr Biol 2010;27:462-8. [PMID: 21142874 DOI: 10.3109/09687688.2010.538936] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
92 Palladini G, Di Pasqua LG, Berardo C, Siciliano V, Richelmi P, Mannucci B, Croce AC, Rizzo V, Perlini S, Vairetti M, Ferrigno A. Fatty Acid Desaturase Involvement in Non-Alcoholic Fatty Liver Disease Rat Models: Oxidative Stress Versus Metalloproteinases. Nutrients 2019;11:E799. [PMID: 30965590 DOI: 10.3390/nu11040799] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
93 Colak Y, Ozturk O, Senates E, Tuncer I, Yorulmaz E, Adali G, Doganay L, Enc FY. SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease. Med Sci Monit. 2011;17:HY5-HY9. [PMID: 21525818 DOI: 10.12659/msm.881749] [Cited by in Crossref: 86] [Cited by in F6Publishing: 56] [Article Influence: 7.8] [Reference Citation Analysis]
94 Pruvost R, Le Stunff H. [Sphingosine kinase-1: role in non alcoholic fatty liver disease]. Med Sci (Paris) 2016;32:716-8. [PMID: 27615179 DOI: 10.1051/medsci/20163208018] [Reference Citation Analysis]
95 Rusu E, Jinga M, Enache G, Rusu F, Dragomir AD, Ancuta I, Draguţ R, Parpala C, Nan R, Sima I, Ateia S, Stoica V, Cheţa DM, Radulian G. Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C--a randomized trial. Nutr J 2013;12:119. [PMID: 23941362 DOI: 10.1186/1475-2891-12-119] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
96 García-compeán D, Jáquez-quintana JO, Lavalle-gonzález FJ, Reyes-cabello E, González-gonzález JA, Muñoz-espinosa LE, Vázquez-elizondo G, Villarreal-pérez JZ, Maldonado-garza HJ. The prevalence and clinical characteristics of glucose metabolism disorders in patients with liver cirrhosis. A prospective study. Annals of Hepatology 2012;11:240-8. [DOI: 10.1016/s1665-2681(19)31030-0] [Cited by in Crossref: 33] [Article Influence: 3.3] [Reference Citation Analysis]
97 Idilman IS, Akata D, Hazirolan T, Doganay Erdogan B, Aytemir K, Karcaaltincaba M. Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients: a computed tomography angiography study 2. J Diabetes. 2015;7:279-286. [PMID: 24893617 DOI: 10.1111/1753-0407.12172] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
98 Valdecantos MP, Pérez-Matute P, Prieto-Hontoria PL, Sánchez-Campayo E, Moreno-Aliaga MJ, Martínez JA. Erythrocyte antioxidant defenses as a potential biomarker of liver mitochondrial status in different oxidative conditions. Biomarkers 2011;16:670-8. [PMID: 21999619 DOI: 10.3109/1354750X.2011.625504] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
99 Tsai IT, Hung WC, Lu YC, Wu CC, Lee TL, Hsuan CF, Yu TH, Wei CT, Chung FM, Lee YJ, Wang CP. Circulating hepassocin level in patients with stable angina is associated with fatty liver and renal function. Int J Med Sci 2021;18:1-7. [PMID: 33390768 DOI: 10.7150/ijms.50646] [Reference Citation Analysis]
100 Arab JP, Candia R, Zapata R, Muñoz C, Arancibia JP, Poniachik J, Soza A, Fuster F, Brahm J, Sanhueza E, Contreras J, Cuellar MC, Arrese M, Riquelme A. Management of nonalcoholic fatty liver disease: An evidence-based clinical practice review. World J Gastroenterol 2014; 20(34): 12182-12201 [PMID: 25232252 DOI: 10.3748/wjg.v20.i34.12182] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
101 Yoon MY, Sung JM, Song CS, Lee WY, Rhee EJ, Shin JH, Yoo CH, Chae SW, Kim JY, Jin W, Cho YK. Enhanced A-FABP expression in visceral fat: potential contributor to the progression of NASH. Clin Mol Hepatol 2012;18:279-86. [PMID: 23091808 DOI: 10.3350/cmh.2012.18.3.279] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
102 Najjar SM, Russo L. CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH). Semin Immunopathol. 2014;36:55-71. [PMID: 24258517 DOI: 10.1007/s00281-013-0407-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
103 Bergholm R, Sevastianova K, Santos A, Kotronen A, Urjansson M, Hakkarainen A, Lundbom J, Tiikkainen M, Rissanen A, Lundbom N, Yki-järvinen H. CB1 blockade-induced weight loss over 48 weeks decreases liver fat in proportion to weight loss in humans. Int J Obes 2013;37:699-703. [DOI: 10.1038/ijo.2012.116] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
104 Patel TP, Rawal K, Soni S, Gupta S. Swertiamarin ameliorates oleic acid induced lipid accumulation and oxidative stress by attenuating gluconeogenesis and lipogenesis in hepatic steatosis. Biomed Pharmacother. 2016;83:785-791. [PMID: 27490779 DOI: 10.1016/j.biopha.2016.07.028] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
105 Chen W, Chang B, Li L, Chan L. Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease. Hepatology. 2010;52:1134-1142. [PMID: 20648554 DOI: 10.1002/hep.23812] [Cited by in Crossref: 153] [Cited by in F6Publishing: 161] [Article Influence: 12.8] [Reference Citation Analysis]
106 Heuer M, Kaiser GM, Kahraman A, Banysch M, Saner FH, Mathé Z, Gerken G, Paul A, Canbay A, Treckmann JW. Liver transplantation in nonalcoholic steatohepatitis is associated with high mortality and post-transplant complications: a single-center experience. Digestion. 2012;86:107-113. [PMID: 22846254 DOI: 10.1159/000339344] [Cited by in Crossref: 32] [Cited by in F6Publishing: 39] [Article Influence: 3.2] [Reference Citation Analysis]
107 Nassir F, Ibdah JA. Role of mitochondria in nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15:8713-8742. [PMID: 24837835 DOI: 10.3390/ijms15058713] [Cited by in Crossref: 148] [Cited by in F6Publishing: 141] [Article Influence: 18.5] [Reference Citation Analysis]
108 Satoh D, Yagi T, Nagasaka T, Shinoura S, Umeda Y, Yoshida R, Utsumi M, Tanaka T, Sadamori H, Fujiwara T. CD14 upregulation as a distinct feature of non-alcoholic fatty liver disease after pancreatoduodenectomy. World J Hepatol 2013; 5(4): 189-195 [PMID: 23671723 DOI: 10.4254/wjh.v5.i4.189] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
109 Roy A, Finegold MJ. Hepatic Neoplasia and Metabolic Diseases in Children. Clinics in Liver Disease 2010;14:731-46. [DOI: 10.1016/j.cld.2010.07.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
110 Sheng L, Jiang B, Rui L. Intracellular lipid content is a key intrinsic determinant for hepatocyte viability and metabolic and inflammatory states in mice. Am J Physiol Endocrinol Metab 2013;305:E1115-23. [PMID: 23982157 DOI: 10.1152/ajpendo.00401.2013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
111 Schwenger KJ, Allard JP. Clinical approaches to non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(7): 1712-1723 [PMID: 24587650 DOI: 10.3748/wjg.v20.i7.1712] [Cited by in CrossRef: 78] [Cited by in F6Publishing: 73] [Article Influence: 9.8] [Reference Citation Analysis]
112 Uysal S, Armutcu F, Aydogan T, Akin K, Ikizek M, Yigitoglu MR. Some inflammatory cytokine levels, iron metabolism and oxidan stress markers in subjects with nonalcoholic steatohepatitis. Clin Biochem 2011;44:1375-9. [PMID: 22015687 DOI: 10.1016/j.clinbiochem.2011.09.017] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
113 Ittermann T, Haring R, Wallaschofski H, Baumeister SE, Nauck M, Dörr M, Lerch MM, Meyer zu Schwabedissen HE, Rosskopf D, Völzke H. Inverse association between serum free thyroxine levels and hepatic steatosis: results from the Study of Health in Pomerania. Thyroid. 2012;22:568-574. [PMID: 22574630 DOI: 10.1089/thy.2011.0279] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 5.9] [Reference Citation Analysis]
114 Idilman IS, Aniktar H, Idilman R, Kabacam G, Savas B, Elhan A, Celik A, Bahar K, Karcaaltincaba M. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology. 2013;267:767-775. [PMID: 23382293 DOI: 10.1148/radiol.13121360] [Cited by in Crossref: 209] [Cited by in F6Publishing: 195] [Article Influence: 23.2] [Reference Citation Analysis]
115 Li L, Liu H, Hu X, Huang Y, Wang Y, He Y, Lei Q. Identification of key genes in non‑alcoholic fatty liver disease progression based on bioinformatics analysis. Mol Med Rep 2018;17:7708-20. [PMID: 29620197 DOI: 10.3892/mmr.2018.8852] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
116 Moon SS, Lee YS, Kim SW. Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women. Endocrine. 2012;42:423-429. [PMID: 22407492 DOI: 10.1007/s12020-012-9639-6] [Cited by in Crossref: 56] [Cited by in F6Publishing: 61] [Article Influence: 5.6] [Reference Citation Analysis]
117 Pasarín M, La Mura V, Gracia-Sancho J, García-Calderó H, Rodríguez-Vilarrupla A, García-Pagán JC, Bosch J, Abraldes JG. Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD. PLoS One. 2012;7:e32785. [PMID: 22509248 DOI: 10.1371/journal,pone.0032785] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
118 Karcz WK, Krawczykowski D, Kuesters S, Marjanovic G, Kulemann B, Grobe H, Karcz-Socha I, Hopt UT, Bukhari W, Grueneberger JM. Influence of Sleeve Gastrectomy on NASH and Type 2 Diabetes Mellitus. J Obes 2011;2011:765473. [PMID: 21274277 DOI: 10.1155/2011/765473] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
119 Pasarín M, La Mura V, Gracia-Sancho J, García-Calderó H, Rodríguez-Vilarrupla A, García-Pagán JC, Bosch J, Abraldes JG. Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD. PLoS One. 2012;7:e32785. [PMID: 22509248 DOI: 10.1371/journal.pone.0032785] [Cited by in Crossref: 122] [Cited by in F6Publishing: 120] [Article Influence: 12.2] [Reference Citation Analysis]
120 Nagahashi M, Takabe K, Liu R, Peng K, Wang X, Wang Y, Hait NC, Wang X, Allegood JC, Yamada A, Aoyagi T, Liang J, Pandak WM, Spiegel S, Hylemon PB, Zhou H. Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression. Hepatology. 2015;61:1216-1226. [PMID: 25363242 DOI: 10.1002/hep.27592] [Cited by in Crossref: 93] [Cited by in F6Publishing: 87] [Article Influence: 13.3] [Reference Citation Analysis]
121 Graff M, North KE, Franceschini N, Reiner AP, Feitosa M, Carr JJ, Gordon-Larsen P, Wojczynski MK, Borecki IB. PNPLA3 gene-by-visceral adipose tissue volume interaction and the pathogenesis of fatty liver disease: the NHLBI family heart study. Int J Obes (Lond) 2013;37:432-8. [PMID: 22546774 DOI: 10.1038/ijo.2012.65] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 3.7] [Reference Citation Analysis]
122 Guo Y, Li JX, Mao TY, Zhao WH, Liu LJ, Wang YL. Targeting Sirt1 in a rat model of high-fat diet-induced non-alcoholic fatty liver disease: Comparison of Gegen Qinlian decoction and resveratrol. Exp Ther Med. 2017;14:4279-4287. [PMID: 29104641 DOI: 10.3892/etm.2017.5076] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
123 Yang SL, Xia JH, Zhang YY, Fan JG, Wang H, Yuan J, Zhao ZZ, Pan Q, Mu YL, Xin LL, Chen YX, Li K. Hyperinsulinemia shifted energy supply from glucose to ketone bodies in early nonalcoholic steatohepatitis from high-fat high-sucrose diet induced Bama minipigs. Sci Rep 2015;5:13980. [PMID: 26358367 DOI: 10.1038/srep13980] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
124 Hamabe A, Uto H, Imamura Y, Kusano K, Mawatari S, Kumagai K, Kure T, Tamai T, Moriuchi A, Sakiyama T. Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period. J Gastroenterol. 2011;46:769-778. [PMID: 21302121 DOI: 10.1007/s00535-011-0376-z] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 7.0] [Reference Citation Analysis]
125 Hur W, Kim SW, Lee YK, Choi JE, Hong SW, Song MJ, Bae SH, Park T, Um S, Yoon SK. Oleuropein reduces free fatty acid-induced lipogenesis via lowered extracellular signal-regulated kinase activation in hepatocytes. Nutrition Research 2012;32:778-86. [DOI: 10.1016/j.nutres.2012.06.017] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
126 Poetter-Lang S, Bastati N, Messner A, Kristic A, Herold A, Hodge JC, Ba-Ssalamah A. Quantification of liver function using gadoxetic acid-enhanced MRI. Abdom Radiol (NY) 2020;45:3532-44. [PMID: 33034671 DOI: 10.1007/s00261-020-02779-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
127 Zhou X, Chen J, Chen J, Wu W, Wang X, Wang Y. The beneficial effects of betaine on dysfunctional adipose tissue and N6-methyladenosine mRNA methylation requires the AMP-activated protein kinase α1 subunit. The Journal of Nutritional Biochemistry 2015;26:1678-84. [DOI: 10.1016/j.jnutbio.2015.08.014] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
128 Wang T, Takikawa Y, Tabuchi T, Satoh T, Kosaka K, Suzuki K. Carnosic acid (CA) prevents lipid accumulation in hepatocytes through the EGFR/MAPK pathway. J Gastroenterol 2012;47:805-13. [DOI: 10.1007/s00535-012-0546-7] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
129 Sangüesa G, Roglans N, Laguna JC, Alegret M. Liquid fructose and liver insulin signaling: Molecular mechanisms controlling hepatic steatosis. Molecular Nutrition: Carbohydrates. Elsevier; 2019. pp. 149-72. [DOI: 10.1016/b978-0-12-849886-6.00004-5] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
130 Lee Y, Friedman SL. Fibrosis in the Liver. Development, Differentiation and Disease of the Para-Alimentary Tract. Elsevier; 2010. pp. 151-200. [DOI: 10.1016/b978-0-12-385233-5.00006-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
131 Oye-Somefun A, Kuk JL, Ardern CI. Associations between elevated kidney and liver biomarker ratios, metabolic syndrome and all-cause and coronary heart disease (CHD) mortality: analysis of the U.S. National Health and Nutrition Examination Survey (NHANES). BMC Cardiovasc Disord 2021;21:352. [PMID: 34311708 DOI: 10.1186/s12872-021-02160-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
132 Comley RA, Kallend D. Imaging in the cardiovascular and metabolic disease area. Drug Discovery Today 2013;18:185-92. [DOI: 10.1016/j.drudis.2012.09.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
133 Scheja L, Kluwe J. Arginine and NASH--do macrophages deliver the first hit? J Hepatol 2015;62:260-1. [PMID: 25450197 DOI: 10.1016/j.jhep.2014.11.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
134 An YM, Jun DW, Lee SM. Development and Application of Low-Carbohydrates and Low-Simple Sugar Nutrition Education Materials for Non-Alcoholic Fatty Liver Disease Patients. Clin Nutr Res 2015;4:250-8. [PMID: 26566520 DOI: 10.7762/cnr.2015.4.4.250] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
135 Adorini L, Pruzanski M, Shapiro D. Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis. Drug Discov Today. 2012;17:988-997. [PMID: 22652341 DOI: 10.1016/j.drudis.2012.05.012] [Cited by in Crossref: 175] [Cited by in F6Publishing: 160] [Article Influence: 17.5] [Reference Citation Analysis]
136 Abdalla MY, Mathahs MM, Ahmad IM. Reduced heme oxygenase-1 expression in steatotic livers infected with hepatitis C virus. Eur J Intern Med. 2012;23:649-655. [PMID: 22939811 DOI: 10.1016/j.ejim.2012.05.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
137 Berlanga A, Guiu-Jurado E, Porras JA, Auguet T. Molecular pathways in non-alcoholic fatty liver disease. Clin Exp Gastroenterol. 2014;7:221-239. [PMID: 25045276 DOI: 10.2147/ceg.s62831] [Cited by in Crossref: 53] [Cited by in F6Publishing: 114] [Article Influence: 6.6] [Reference Citation Analysis]
138 Pár G, Horváth G, Pár A. [Non-alcoholic fatty liver disease and steatohepatitis]. Orv Hetil 2013;154:1124-34. [PMID: 23853345 DOI: 10.1556/OH.2013.29626] [Reference Citation Analysis]
139 Lin C, Rountree CB, Methratta S, LaRusso S, Kunselman AR, Spanier AJ. Secondhand tobacco exposure is associated with nonalcoholic fatty liver disease in children. Environ Res 2014;132:264-8. [PMID: 24834820 DOI: 10.1016/j.envres.2014.04.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
140 Long W, Hui Ju Z, Fan Z, Jing W, Qiong L. The effect of recombinant adeno-associated virus-adiponectin (rAAV2/1-Acrp30) on glycolipid dysmetabolism and liver morphology in diabetic rats. Gen Comp Endocrinol. 2014;206:1-7. [PMID: 25019654 DOI: 10.1016/j.ygcen.2014.07.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
141 Shim JJ. Body iron, serum ferritin, and nonalcoholic fatty liver disease. Korean J Hepatol 2012;18:105-7. [PMID: 22511912 DOI: 10.3350/kjhep.2012.18.1.105] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
142 Sandboge S, Perälä M, Salonen MK, Blomstedt PA, Osmond C, Kajantie E, Barker DJP, Eriksson JG. Early growth and non-alcoholic fatty liver disease in adulthood—the NAFLD liver fat score and equation applied on the Helsinki Birth Cohort Study. Annals of Medicine 2013;45:430-7. [DOI: 10.3109/07853890.2013.801275] [Cited by in Crossref: 83] [Cited by in F6Publishing: 24] [Article Influence: 9.2] [Reference Citation Analysis]
143 Yang Y, Zhao Y, Li W, Wu Y, Wang X, Wang Y, Liu T, Ye T, Xie Y, Cheng Z, He J, Bai P, Zhang Y, Ouyang L. Emerging targets and potential therapeutic agents in non-alcoholic fatty liver disease treatment. Eur J Med Chem 2020;197:112311. [PMID: 32339855 DOI: 10.1016/j.ejmech.2020.112311] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
144 Song Y, Joo H, Park I, Shen G, Lee Y, Shin JH, Kim H, Kim K. Granulocyte-colony stimulating factor prevents the development of hepatic steatosis in rats. Annals of Hepatology 2015;14:243-50. [DOI: 10.1016/s1665-2681(19)30787-2] [Cited by in Crossref: 5] [Article Influence: 0.7] [Reference Citation Analysis]
145 Jiang D. Care of chronic liver disease. Prim Care 2011;38:483-98; viii-ix. [PMID: 21872093 DOI: 10.1016/j.pop.2011.05.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
146 Parlevliet ET, Wang Y, Geerling JJ, Schröder-Van der Elst JP, Picha K, O'Neil K, Stojanovic-Susulic V, Ort T, Havekes LM, Romijn JA, Pijl H, Rensen PC. GLP-1 receptor activation inhibits VLDL production and reverses hepatic steatosis by decreasing hepatic lipogenesis in high-fat-fed APOE*3-Leiden mice. PLoS One 2012;7:e49152. [PMID: 23133675 DOI: 10.1371/journal.pone.0049152] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 4.9] [Reference Citation Analysis]
147 Chiu WC, Yang HH, Chiang SC, Chou YX, Yang HT. Auricularia polytricha aqueous extract supplementation decreases hepatic lipid accumulation and improves antioxidative status in animal model of nonalcoholic fatty liver. Biomedicine (Taipei) 2014;4:12. [PMID: 25520925 DOI: 10.7603/s40681-014-0012-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
148 Iloon Kashkooli R, Najafi SS, Sharif F, Hamedi A, Hoseini Asl MK, Najafi Kalyani M, Birjandi M. The effect of berberis vulgaris extract on transaminase activities in non-alcoholic Fatty liver disease. Hepat Mon 2015;15:e25067. [PMID: 25788958 DOI: 10.5812/hepatmon.25067] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
149 Afsharinasab M, Mohammad-Sadeghipour M, Reza Hajizadeh M, Khoshdel A, Mirzaiey V, Mahmoodi M. The effect of hydroalcoholic Berberis integerrima fruits extract on the lipid profile, antioxidant parameters and liver and kidney function tests in patients with nonalcoholic fatty liver disease. Saudi J Biol Sci 2020;27:2031-7. [PMID: 32742180 DOI: 10.1016/j.sjbs.2020.04.037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
150 Xiao J, Lv D, Zhao Y, Chen X, Song M, Liu J, Bei Y, Wang F, Yang W, Yang C. miR-149 controls non-alcoholic fatty liver by targeting FGF-21. J Cell Mol Med. 2016;20:1603-1608. [PMID: 27061435 DOI: 10.1111/jcmm.12848] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
151 Guo J, Fang W, Sun L, Lu Y, Dou L, Huang X, Sun M, Pang C, Qu J, Liu G, Li J. Reduced miR-200b and miR-200c expression contributes to abnormal hepatic lipid accumulation by stimulating JUN expression and activating the transcription of srebp1. Oncotarget 2016;7:36207-19. [PMID: 27166182 DOI: 10.18632/oncotarget.9183] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
152 Jung KY, Cho SY, Kim HJ, Kim SB, Song IH. Nonalcoholic Steatohepatitis Associated With Metabolic Syndrome: Relationship to Insulin Resistance and Liver Histology. Journal of Clinical Gastroenterology 2014;48:883-8. [DOI: 10.1097/mcg.0000000000000065] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
153 Harsha Varma S, Tirupati S, Pradeep TVS, Sarathi V, Kumar D. Insulin resistance and hyperandrogenemia independently predict nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Diabetes Metab Syndr 2019;13:1065-9. [PMID: 31336445 DOI: 10.1016/j.dsx.2018.12.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
154 Weiß J, Rau M, Geier A. Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment. Dtsch Arztebl Int 2014;111:447-52. [PMID: 25019921 DOI: 10.3238/arztebl.2014.0447] [Cited by in Crossref: 19] [Cited by in F6Publishing: 42] [Article Influence: 2.7] [Reference Citation Analysis]
155 Schwenger KJ, Allard JP. Clinical approaches to non-alcoholic fatty liver disease. World J Gastroenterol. 2014;20:1712-1723. [PMID: 24587650 DOI: 10.3478/wjg.v20.i7.1712] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
156 García-Compeán D, Jáquez-Quintana JO, Lavalle-González FJ, González-González JA, Muñoz-Espinosa LE, Villarreal-Pérez JZ, Maldonado-Garza HJ. Subclinical abnormal glucose tolerance is a predictor of death in liver cirrhosis. World J Gastroenterol 2014; 20(22): 7011-7018 [PMID: 24944496 DOI: 10.3748/wjg.v20.i22.7011] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
157 Öner-İyidoğan Y, Koçak H, Seyidhanoğlu M, Gürdöl F, Gülçubuk A, Yildirim F, Çevik A, Uysal M. Curcumin prevents liver fat accumulation and serum fetuin-A increase in rats fed a high-fat diet. J Physiol Biochem 2013;69:677-86. [PMID: 23430567 DOI: 10.1007/s13105-013-0244-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
158 Polyzos SA, Kountouras J, Zafeiriadou E, Patsiaoura K, Katsiki E, Deretzi G, Zavos C, Tsarouchas G, Rakitzi P, Slavakis A. Effect of spironolactone and vitamin E on serum metabolic parameters and insulin resistance in patients with nonalcoholic fatty liver disease. J Renin Angiotensin Aldosterone Syst 2011;12:498-503. [DOI: 10.1177/1470320311402110] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
159 Yuan S, Liu H, Yuan D, Xu J, Chen Y, Xu X, Xu F, Liang H. PNPLA3 I148M mediates the regulatory effect of NF-kB on inflammation in PA-treated HepG2 cells. J Cell Mol Med 2020;24:1541-52. [PMID: 31793207 DOI: 10.1111/jcmm.14839] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
160 Lee JY, Moon JH, Park JS, Lee BW, Kang ES, Ahn CW, Lee HC, Cha BS. Dietary oleate has beneficial effects on every step of non-alcoholic Fatty liver disease progression in a methionine- and choline-deficient diet-fed animal model. Diabetes Metab J 2011;35:489-96. [PMID: 22111040 DOI: 10.4093/dmj.2011.35.5.489] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
161 Wang T, Takikawa Y, Satoh T, Yoshioka Y, Kosaka K, Tatemichi Y, Suzuki K. Carnosic acid prevents obesity and hepatic steatosis in ob/ob mice. Hepatol Res 2011;41:87-92. [PMID: 21199201 DOI: 10.1111/j.1872-034X.2010.00747.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
162 Jiang H, Guan Q, Xiao Y, Feng Z, Yu G, Pan Q. Strontium Alleviates Endoplasmic Reticulum Stress in a Nonalcoholic Fatty Liver Disease Model. J Med Food 2018. [PMID: 30457429 DOI: 10.1089/jmf.2018.4186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
163 Hojo M, Watanabe S. Pharmacological therapy of nonalcoholic steatohepatitis: Therapeutic value of NASH treatments. Hepatology Research 2011;41:209-16. [DOI: 10.1111/j.1872-034x.2011.00780.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
164 Laverty HG, Antoine DJ, Benson C, Chaponda M, Williams D, Park BK. The potential of cytokines as safety biomarkers for drug-induced liver injury. Eur J Clin Pharmacol 2010;66:961-76. [DOI: 10.1007/s00228-010-0862-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
165 Chanu Thounaojam M, Navalsinh Jadeja R, Devkar RV, Vadathala Ramachandran A. Non-alcoholic steatohepatitis: an overview including treatments with herbals as alternative therapeutics. J Appl Biomed 2012;10:119-36. [DOI: 10.2478/v10136-012-0008-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
166 Qu BG, Bi W, Jia YG, Liu YX, Wang H, Su JL, Liu LL, Wang ZD, Wang YF, Han XH, Pan JD, Ren GY, Hu WJ. Association between circulating inflammatory molecules and alcoholic liver disease in men. Cell Stress Chaperones 2016;21:865-72. [PMID: 27329162 DOI: 10.1007/s12192-016-0711-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
167 Cordeiro A, Pereira SE, Saboya CJ, Ramalho A. Nonalcoholic Fatty Liver Disease Relationship with Metabolic Syndrome in Class III Obesity Individuals. Biomed Res Int 2015;2015:839253. [PMID: 26120587 DOI: 10.1155/2015/839253] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
168 Satapathy SK, Nair S, Vanatta JM. Nonalcoholic fatty liver disease following liver transplantation. Hepatol Int 2013;7:400-12. [PMID: 26201774 DOI: 10.1007/s12072-013-9434-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
169 Rui L. Energy metabolism in the liver. Compr Physiol. 2014;4:177-197. [PMID: 24692138 DOI: 10.1002/cphy.c130024] [Cited by in Crossref: 700] [Cited by in F6Publishing: 681] [Article Influence: 87.5] [Reference Citation Analysis]
170 Jiang Z, Bo L, Meng Y, Wang C, Chen T, Wang C, Yu X, Deng X. Overexpression of homeodomain-interacting protein kinase 2 (HIPK2) attenuates sepsis-mediated liver injury by restoring autophagy. Cell Death Dis 2018;9:847. [PMID: 30154452 DOI: 10.1038/s41419-018-0838-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
171 Jadeja RN, Devkar RV. Polyphenols and Flavonoids in Controlling Non-Alcoholic Steatohepatitis. Polyphenols in Human Health and Disease. Elsevier; 2014. pp. 615-23. [DOI: 10.1016/b978-0-12-398456-2.00047-5] [Cited by in Crossref: 12] [Article Influence: 1.5] [Reference Citation Analysis]
172 Audsley J, du Cros P, Goodman Z, Mclean C, Mijch A, Lewin SR, Sasadeusz J. HIV replication is associated with increased severity of liver biopsy changes in HIV-HBV and HIV-HCV co-infection. J Med Virol 2012;84:993-1001. [DOI: 10.1002/jmv.23236] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
173 Obika M, Noguchi H. Diagnosis and evaluation of nonalcoholic fatty liver disease. Exp Diabetes Res. 2012;2012:145754. [PMID: 22110476 DOI: 10.1155/2012/145754] [Cited by in Crossref: 114] [Cited by in F6Publishing: 116] [Article Influence: 10.4] [Reference Citation Analysis]
174 Briata P, Bordo D, Puppo M, Gorlero F, Rossi M, Perrone-Bizzozero N, Gherzi R. Diverse roles of the nucleic acid-binding protein KHSRP in cell differentiation and disease. Wiley Interdiscip Rev RNA 2016;7:227-40. [PMID: 26708421 DOI: 10.1002/wrna.1327] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
175 Lee TH, Han SH, Yang JD, Kim D, Ahmed M. Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score. Gut Liver 2013;7:323-8. [PMID: 23710314 DOI: 10.5009/gnl.2013.7.3.323] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
176 Canup BS, Song H, Laroui H. Role of CD98 in liver disease. Annals of Hepatology 2020;19:602-7. [DOI: 10.1016/j.aohep.2019.11.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
177 Joo SK, Kim W, Kim D, Kim JH, Oh S, Lee KL, Chang MS, Jung YJ, So YH, Lee MS, Bae JM, Kim BG. Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease. Liver Int. 2018;38:331-341. [PMID: 28796410 DOI: 10.1111/liv.13549] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
178 Motosugi U, Ichikawa T, Niitsuma Y, Araki T. Acoustic radiation force impulse elastography of the liver: can fat deposition in the liver affect the measurement of liver stiffness? Jpn J Radiol. 2011;29:639-643. [PMID: 21956369 DOI: 10.1007/s11604-011-0607-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
179 Sheng L, Cho KW, Zhou Y, Shen H, Rui L. Lipocalin 13 protein protects against hepatic steatosis by both inhibiting lipogenesis and stimulating fatty acid β-oxidation. J Biol Chem 2011;286:38128-35. [PMID: 21908604 DOI: 10.1074/jbc.M111.256677] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
180 Ghamarchehreh ME, Jonaidi-Jafari N, Bigdeli M, Khedmat H, Saburi A. Iron Status and Metabolic Syndrome in Patients with Non-Alcoholic Fatty Liver Disease. Middle East J Dig Dis. 2016;8:31-38. [PMID: 26933479 DOI: 10.15171/mejdd.2016.04] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
181 Abd El-Kader SM, Al-Jiffri OH, Al-Shreef FM. Markers of liver function and inflammatory cytokines modulation by aerobic versus resisted exercise training for nonalcoholic steatohepatitis patients. Afr Health Sci 2014;14:551-7. [PMID: 25352871 DOI: 10.4314/ahs.v14i3.8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
182 Wei W, Zhang YJ, Xu L, Xu L, Li P, Pan ZH, Liu YG, Mi YQ. Effects of Jiangan Jiangzhi pill on liver oxidative stress in rats with non-alcoholic fatty liver disease. Shijie Huaren Xiaohua Zazhi 2014; 22(31): 4790-4794 [DOI: 10.11569/wcjd.v22.i31.4790] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
183 Hadjihambi A. Cerebrovascular alterations in NAFLD: Is it increasing our risk of Alzheimer's disease? Anal Biochem 2021;:114387. [PMID: 34537182 DOI: 10.1016/j.ab.2021.114387] [Reference Citation Analysis]
184 Hattar LN, Wilson TA, Tabotabo LA, Smith EO, Abrams SH. Physical activity and nutrition attitudes in obese Hispanic children with non-alcoholic steatohepatitis. World J Gastroenterol 2011; 17(39): 4396-4403 [PMID: 22110265 DOI: 10.3748/wjg.v17.i39.4396] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
185 Alrashood ST, Al-Asmari AK, Alotaibi AK, Manthiri RA, Rafatullah S, Hasanato RM, Khan HA, Ibrahim KE, Wali AF. Protective effect of lyophilized sapodilla (Manilkara zapota) fruit extract against CCl4-induced liver damage in rats. Saudi J Biol Sci 2020;27:2373-9. [PMID: 32884419 DOI: 10.1016/j.sjbs.2020.05.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Laguna JC, Alegret M, Roglans N. Simple sugar intake and hepatocellular carcinoma: epidemiological and mechanistic insight. Nutrients 2014;6:5933-54. [PMID: 25533006 DOI: 10.3390/nu6125933] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
187 Liu Y, Sheng L, Xiong Y, Shen H, Liu Y, Rui L. Liver NF-κB-Inducing Kinase Promotes Liver Steatosis and Glucose Counterregulation in Male Mice With Obesity. Endocrinology 2017;158:1207-16. [PMID: 28379340 DOI: 10.1210/en.2016-1582] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
188 Kaya M, Işık D, Beştaş R, Evliyaoğlu O, Akpolat V, Büyükbayram H, Kaplan MA. Increased bone mineral density in patients with non-alcoholic steatohepatitis. World J Hepatol 2013; 5(11): 627-634 [PMID: 24303091 DOI: 10.4254/wjh.v5.i11.627] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
189 Kim KY, Song JS, Kannengiesser S, Han YM. Hepatic fat quantification using the proton density fat fraction (PDFF): utility of free-drawn-PDFF with a large coverage area. Radiol Med 2015;120:1083-93. [PMID: 25952293 DOI: 10.1007/s11547-015-0545-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
190 Cho JY, Chung TH, Lim KM, Park HJ, Jang JM. The impact of weight changes on nonalcoholic Fatty liver disease in adult men with normal weight. Korean J Fam Med. 2014;35:243-250. [PMID: 25309705 DOI: 10.4082/kjfm.2014.35.5.243] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
191 Della Corte C, Alisi A, Iorio R, Alterio A, Nobili V. Expert opinion on current therapies for nonalcoholic fatty liver disease. Expert Opin Pharmacother. 2011;12:1901-1911. [PMID: 21639814 DOI: 10.1517/14656566.2011.587123] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
192 Hagymási K, Lengyel G. Non-alcoholic steatosis/steatohepatitis – 2010. Orvosi Hetilap 2010;151:1940-5. [DOI: 10.1556/oh.2010.28989] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
193 Ezquer M, Ezquer F, Ricca M, Allers C, Conget P. Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome. J Hepatol 2011;55:1112-20. [PMID: 21356258 DOI: 10.1016/j.jhep.2011.02.020] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
194 Muangpaisarn P, Jampoka K, Payungporn S, Wisedopas N, Bunchorntavakul C, Tangkijvanich P, Treeprasertsuk S. Serum microRNA-34a is potential biomarker for inflammation in nonalcoholic fatty liver disease. Asian Biomedicine 2017;10:163-71. [DOI: 10.5372/1905-7415.1002.478] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
195 Demir M, Lang S, Nierhoff D, Drebber U, Hardt A, Wedemeyer I, Schulte S, Quasdorff M, Goeser T, Töx U, Steffen H. Stepwise Combination of Simple Noninvasive Fibrosis Scoring Systems Increases Diagnostic Accuracy in Nonalcoholic Fatty Liver Disease. Journal of Clinical Gastroenterology 2013;47:719-26. [DOI: 10.1097/mcg.0b013e3182819a89] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
196 Miao H, Zhang Y, Lu Z, Yu L, Gan L. FOXO1 increases CCL20 to promote NF-κB-dependent lymphocyte chemotaxis. Mol Endocrinol 2012;26:423-37. [PMID: 22240809 DOI: 10.1210/me.2011-1233] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
197 Xu Y, Zalzala M, Xu J, Li Y, Yin L, Zhang Y. A metabolic stress-inducible miR-34a-HNF4α pathway regulates lipid and lipoprotein metabolism. Nat Commun 2015;6:7466. [PMID: 26100857 DOI: 10.1038/ncomms8466] [Cited by in Crossref: 117] [Cited by in F6Publishing: 115] [Article Influence: 16.7] [Reference Citation Analysis]
198 Zhang Q, Zhao Y, Wu J, Xie L, Chen A, Liu Y, Song Q, Li J, Wu T, Xie L, Liu A. Quantification of Hepatic Fat Fraction in Patients With Nonalcoholic Fatty Liver Disease: Comparison of Multimaterial Decomposition Algorithm and Fat (Water)-Based Material Decomposition Algorithm Using Single-Source Dual-Energy Computed Tomography. J Comput Assist Tomogr 2021;45:12-7. [PMID: 33186174 DOI: 10.1097/RCT.0000000000001112] [Reference Citation Analysis]
199 Valdecantos MP, Pérez-matute P, González-muniesa P, Prieto-hontoria PL, Moreno-aliaga MJ, Martínez JA. Lipoic Acid Improves Mitochondrial Function in Nonalcoholic Steatosis Through the Stimulation of Sirtuin 1 and Sirtuin 3. Obesity 2012;20:1974-83. [DOI: 10.1038/oby.2012.32] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 5.8] [Reference Citation Analysis]
200 Belemets N, Kobyliak N, Falalyeyeva T, Kuryk O, Sulaieva O, Vovk T, Beregova T, Ostapchenko L. Polyphenol Compounds Melanin Prevented Hepatic Inflammation in Rats with Experimental Obesity. Natural Product Communications 2018;13:1934578X1801301. [DOI: 10.1177/1934578x1801301118] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
201 Fink A, Rüfer CE, Le Grandois J, Roth A, Aoude-Werner D, Marchioni E, Bub A, Barth SW. Dietary walnut oil modulates liver steatosis in the obese Zucker rat. Eur J Nutr 2014;53:645-60. [PMID: 23942585 DOI: 10.1007/s00394-013-0573-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
202 Moon SS, Lee YS, Kim JG, Lee IK. Association of 11β-hydroxysteroid dehydrogenase type 1 gene polymorphisms with serum alanine aminotransferase activity. Diabetes Res Clin Pract 2013;99:343-50. [PMID: 23375992 DOI: 10.1016/j.diabres.2012.12.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
203 Akhondi-Meybodi M, Mortazavy-Zadah MR, Hashemian Z, Moaiedi M. Incidence and risk factors for non-alcoholic steatohepatitis in females treated with tamoxifen for breast cancer. Arab J Gastroenterol 2011;12:34-6. [PMID: 21429453 DOI: 10.1016/j.ajg.2011.01.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
204 Chiang CH, Yang HI, Jen CL, Lu SN, Wang LY, You SL, Su J, Iloeje UH, Chen CJ; REVEAL-HBV Study Group. Association between obesity, hypertriglyceridemia and low hepatitis B viral load. Int J Obes (Lond). 2013;37:410-415. [PMID: 22531094 DOI: 10.1038/ijo.2012.63] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
205 Mazza A, Fruci B, Garinis GA, Giuliano S, Malaguarnera R, Belfiore A. The role of metformin in the management of NAFLD. Exp Diabetes Res. 2012;2012:716404. [PMID: 22194737 DOI: 10.1155/2012/716404] [Cited by in Crossref: 98] [Cited by in F6Publishing: 100] [Article Influence: 8.9] [Reference Citation Analysis]
206 Gentile CL, Frye MA, Pagliassotti MJ. Fatty acids and the endoplasmic reticulum in nonalcoholic fatty liver disease. Biofactors 2011;37:8-16. [PMID: 21328622 DOI: 10.1002/biof.135] [Cited by in Crossref: 97] [Cited by in F6Publishing: 64] [Article Influence: 8.1] [Reference Citation Analysis]
207 Chen W, Chen C, Liu C, Mao FC. Chromium attenuates high-fat diet-induced nonalcoholic fatty liver disease in KK/HlJ mice. Biochemical and Biophysical Research Communications 2010;397:459-64. [DOI: 10.1016/j.bbrc.2010.05.129] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
208 Ferramosca A, Zara V. Modulation of hepatic steatosis by dietary fatty acids. World J Gastroenterol 2014; 20(7): 1746-1755 [PMID: 24587652 DOI: 10.3748/wjg.v20.i7.1746] [Cited by in CrossRef: 99] [Cited by in F6Publishing: 90] [Article Influence: 12.4] [Reference Citation Analysis]
209 Rezazadeh A, Yazdanparast R, Molaei M. Amelioration of diet-induced nonalcoholic steatohepatitis in rats by Mn-salen complexes via reduction of oxidative stress.J Biomed Sci. 2012;19:26. [PMID: 22375551 DOI: 10.1186/1423-0127-19-26] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
210 Zhang L, Zhang Z, Li Y, Liao S, Wu X, Chang Q, Liang B. Cholesterol induces lipoprotein lipase expression in a tree shrew (Tupaia belangeri chinensis) model of non-alcoholic fatty liver disease. Sci Rep 2015;5:15970. [PMID: 26522240 DOI: 10.1038/srep15970] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
211 Fierbinteanu-Braticevici C, Dina I, Petrisor A, Tribus L, Negreanu L, Carstoiu C. Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis. World J Gastroenterol 2010; 16(38): 4784-4791 [PMID: 20939106 DOI: 10.3748/wjg.v16.i38.4784] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 40] [Article Influence: 3.4] [Reference Citation Analysis]
212 Illnait J, Rodríguez I, Mendoza S, Fernández Y, Mas R, Miranda M, Piñera J, Fernández JC, Mesa M, Fernández L, Carbajal D, Gámez R. Effects of D-002, a mixture of high molecular weight beeswax alcohols, on patients with nonalcoholic fatty liver disease. Korean J Intern Med 2013;28:439-48. [PMID: 23864802 DOI: 10.3904/kjim.2013.28.4.439] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
213 North KE, Graff M, Franceschini N, Reiner AP, Feitosa MF, Carr JJ, Gordon-Larsen P, Wojczynski MK, Borecki IB. Sex and race differences in the prevalence of fatty liver disease as measured by computed tomography liver attenuation in European American and African American participants of the NHLBI family heart study. Eur J Gastroenterol Hepatol. 2012;24:9-16. [PMID: 21900826 DOI: 10.1097/meg.0b013e32834a94fb] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
214 Shen H, Sheng L, Xiong Y, Kim YH, Jiang L, Chen Z, Liu Y, Pyaram K, Chang CH, Rui L. Thymic NF-κB-inducing kinase regulates CD4+ T cell-elicited liver injury and fibrosis in mice. J Hepatol 2017;67:100-9. [PMID: 28267623 DOI: 10.1016/j.jhep.2017.02.025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
215 Canup BS, Song H, Le Ngo V, Meng X, Denning TL, Garg P, Laroui H. CD98 siRNA-loaded nanoparticles decrease hepatic steatosis in mice. Dig Liver Dis 2017;49:188-96. [PMID: 27939923 DOI: 10.1016/j.dld.2016.11.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
216 Khaw KB, Choi RH, Kam JH, Chakraborty B, Chow PK. Interval increase in the prevalence of symptomatic cholelithiasis-associated non-alcoholic fatty liver disease over a ten-year period in an Asian population. Singapore Med J 2017;58:703-7. [PMID: 27995261 DOI: 10.11622/smedj.2016189] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]